Innocan Pharma Corp. Stock
Price
Target price
€4.52
€4.52
-6.300%
-0.3
-6.300%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Innocan Pharma Corp. Stock
Innocan Pharma Corp. took a tumble today and lost -€0.300 (-6.300%).
Pros and Cons of Innocan Pharma Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
News
Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M
Herzliya, Israel and Calgary, Alberta – November 27, 2025 – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the “Company” or “Innocan”), a pharmaceutical technology company
Innocan Pharma Announces Promising Translational Evidence from a Pain Relief Study of Repeated LPT-CBD Administration in Goats
Herzliya, Israel and Calgary, Alberta – 24 November 2025 – Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) (“Innocan” or the “Company”), a pioneer in the pharmaceutical and
Innocan Pharma announces promising results of LPT-CBD administered to Gottingen Minipigs, a well-known drug toxicology model
Herzliya, Israel and Calgary, Alberta –20 November, 2025 – Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) (“Innocan” or the “Company”), a pioneer in the pharmaceutical and